{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:18:15Z","timestamp":1789499895720,"version":"build-2803163510"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Acute myeloid leukemia (AML) is a heterogeneous blood cancer that arises from transformed myeloid precursor cells in a compromised bone marrow microenvironment. This environment is essential for AML initiation, progression, and relapse. Alongside oncogenic changes in hematopoietic cells, immunological dysregulation also contributes to leukemogenesis. The present study is aimed to identify prognostic genes in stromal and immune cells associated with AML using the weighted gene co-expression network analysis (WGCNA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Gene expression profiles were retrieved from The Cancer Genome Atlas database, and immune and stromal cell scores were calculated using the ESTIMATE (Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data) method. These scores helped identify differentially expressed genes (DEGs), which were then used to create gene clusters through WGCNA. To explore the functions of genes linked to AML subtypes, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed. A protein\u2013protein interaction network was developed to identify hub genes. The top 18 hub genes were identified using the cytoHubba plug-in in Cytoscape software, and survival analysis was conducted with the Gene Expression Profiling Interactive Analysis 2 online tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 1097 DEGs were identified, with 601 being upregulated and 496 downregulated. WGCNA analysis indicated that the gray module, comprising 165 genes, had the strongest association with AML subtypes (Cor\u2005&gt;\u20050.3;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). Gene Ontology enrichment analysis demonstrated that the 18 identified hub genes were predominantly associated with neutrophil activation, immune response, secretory granule membrane, and pattern recognition receptor activity. Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis revealed that the DEGs were mainly involved in pathways related to phagosome, lysosome, tuberculosis, leishmaniasis, and neutrophil extracellular trap formation. Kaplan\u2013Meier survival analysis of the top 18 hub genes indicated that ITGAM, IL10, and CD163 were significantly correlated with survival outcomes in AML.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Key stromal and immune-related genes influencing AML patient outcomes were identified, highlighting their potential as therapeutic targets. These discoveries provide deeper insights into the molecular mechanisms driving AML pathogenesis and subtype differentiation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044062","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:02:02Z","timestamp":1762210922000},"page":"e44062","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Exploring prognostic genes in the immune microenvironment of acute myeloid leukemia via weighted gene co-expression network analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1544-9751","authenticated-orcid":false,"given":"Xiao","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Lou","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxia","family":"Bai","sequence":"additional","affiliation":[{"name":"Hematology Laboratory, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","article-title":"Acute myeloid leukaemia.","volume":"392","author":"Short","year":"2018","journal-title":"Lancet"},{"issue":"Supplement 1","key":"R2-20260915","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1182\/blood-2022-167039","article-title":"Mesenchymal stromal cell secretome in acute myeloid leukemia bone marrow niche.","volume":"140","author":"Borella","year":"2022","journal-title":"Blood"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3390\/biomedicines12081915","article-title":"The role of epithelial-to-mesenchymal transition transcription factors (EMT-TFs) in acute myeloid leukemia progression.","volume":"12","author":"Cuevas","year":"2024","journal-title":"Biomedicines"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"103350","DOI":"10.1016\/j.isci.2021.103350","article-title":"The long non-coding RNA CDK6-AS1 overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamics.","volume":"24","author":"Porcu","year":"2021","journal-title":"iScience"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/bjh.15032","article-title":"Advances in targeted therapy for acute myeloid leukaemia.","volume":"180","author":"Kayser","year":"2018","journal-title":"Br J Haematol"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"109915","DOI":"10.18632\/oncotarget.18565","article-title":"Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase.","volume":"8","author":"Bertuccio","year":"2017","journal-title":"Oncotarget"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.blre.2017.08.010","article-title":"Patient-reported outcomes in acute myeloid leukemia: where are we now?","volume":"32","author":"Buckley","year":"2018","journal-title":"Blood Rev"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1158\/0008-5472.CAN-16-1095","article-title":"MIF-induced stromal PKCbeta\/IL8 is essential in human acute myeloid leukemia.","volume":"77","author":"Abdul-Aziz","year":"2017","journal-title":"Cancer Res"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood-2011-11-393934","article-title":"Targeting of mTORC1\/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment.","volume":"120","author":"Zeng","year":"2012","journal-title":"Blood"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"e70152","DOI":"10.1002\/cam4.70152","article-title":"Immune-dysregulation harnessing in myeloid neoplasms.","volume":"13","author":"Sharifi","year":"2024","journal-title":"Cancer Med"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/leu.2009.175","article-title":"Contribution of bone microenvironment to leukemogenesis and leukemia progression.","volume":"23","author":"Ayala","year":"2009","journal-title":"Leukemia"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"1204895","DOI":"10.3389\/fonc.2023.1204895","article-title":"Therapeutic targeting of leukemia stem cells in acute myeloid leukemia.","volume":"13","author":"Barbosa","year":"2023","journal-title":"Front Oncol"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13045-017-0396-0","article-title":"Hh\/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.","volume":"10","author":"Masetti","year":"2017","journal-title":"J Hematol Oncol"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"875510","DOI":"10.3389\/fped.2022.875510","article-title":"Case report: the value of genomic analysis in a case of megakaryoblastic leukemia with atypical initial manifestation.","volume":"10","author":"Gutierrez-Jimeno","year":"2022","journal-title":"Front Pediatr"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3389\/fcell.2020.00607","article-title":"Leukemia stem cell release from the stem cell niche to treat acute myeloid leukemia.","volume":"8","author":"Villatoro","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.critrevonc.2016.04.020","article-title":"Harnessing the immune system in acute myeloid leukaemia.","volume":"103","author":"Austin","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/ijc.32063","article-title":"Abnormal morphological and functional nature of bone marrow stromal cells provides preferential support for survival of acute myeloid leukemia cells.","volume":"144","author":"Yehudai-Resheff","year":"2019","journal-title":"Int J Cancer"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/bjh.16310","article-title":"Acute myeloid leukaemia and the immune system: implications for immunotherapy.","volume":"188","author":"Barrett","year":"2020","journal-title":"Br J Haematol"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1158\/1078-0432.CCR-17-3016","article-title":"Novel approaches to acute myeloid leukemia immunotherapy.","volume":"24","author":"Beyar-Katz","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1172\/JCI129204","article-title":"Immune escape and immunotherapy of acute myeloid leukemia.","volume":"130","author":"Vago","year":"2020","journal-title":"J Clin Invest"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1007\/s00277-024-05963-x","article-title":"Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia.","volume":"103","author":"Prajapati","year":"2024","journal-title":"Ann Hematol"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1007\/s00277-024-05987-3","article-title":"The role of long noncoding RNAs in the diagnosis, prognosis and therapeutic biomarkers of acute myeloid leukemia.","volume":"103","author":"Atnaf","year":"2024","journal-title":"Ann Hematol"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data.","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00262-019-02408-7","article-title":"Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis.","volume":"68","author":"Yan","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13578-020-00481-5","article-title":"Clusterization in acute myeloid leukemia based on prognostic alternative splicing signature to reveal the clinical characteristics in the bone marrow microenvironment.","volume":"10","author":"Zhang","year":"2020","journal-title":"Cell Biosci"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/ani14010080","article-title":"Weighted gene co-expression network analysis based on stimulation by lipopolysaccharides and polyinosinic:polycytidylic acid provides a core set of genes for understanding hemolymph immune response mechanisms of amphioctopus fangsiao.","volume":"14","author":"Wang","year":"2023","journal-title":"Animals (Basel)"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jcmgh.2016.05.003","article-title":"Microgeographic proteomic networks of the human colonic mucosa and their association with inflammatory bowel disease.","volume":"2","author":"Li","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/1756-185X.13063","article-title":"Identifying key genes in rheumatoid arthritis by weighted gene co-expression network analysis.","volume":"20","author":"Ma","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"912526","DOI":"10.3389\/fimmu.2022.912526","article-title":"One stone, two birds: n6-methyladenosine rna modification in leukemia stem cells and the tumor immune microenvironment in acute myeloid leukemia.","volume":"13","author":"Ouyang","year":"2022","journal-title":"Front Immunol"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"854973","DOI":"10.3389\/fonc.2022.854973","article-title":"Murine models of acute myeloid leukemia.","volume":"12","author":"Kurtz","year":"2022","journal-title":"Front Oncol"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12859-017-1576-1","article-title":"Enhanced construction of gene regulatory networks using hub gene information.","volume":"18","author":"Yu","year":"2017","journal-title":"BMC Bioinf"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis.","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"641629","DOI":"10.3389\/fcell.2021.641629","article-title":"Dysregulation of miR-138-5p\/RPS6KA1-AP2M1 is associated with poor prognosis in AML.","volume":"9","author":"Yu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R37-20260915","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12935-025-03779-x","article-title":"Prognostic value of natural killer T cell related genes in acute myeloid leukemia.","volume":"25","author":"Liu","year":"2025","journal-title":"Cancer Cell Int"},{"key":"R38-20260915","first-page":"100016","article-title":"Impact of IGF3 stimulation on spotted scat (Scatophagus argus) liver: implications for a role in ovarian development.","volume":"1","author":"Li","year":"2023","journal-title":"Agric Commun"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.963931","article-title":"Exploration of immune response mechanisms in cadmium and copper co-exposed juvenile golden cuttlefish (Sepia esculenta) based on transcriptome profiling.","volume":"13","author":"Bao","year":"2022","journal-title":"Front Immunol"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1182\/blood-2018-04-845420","article-title":"Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.","volume":"133","author":"Abdul-Aziz","year":"2019","journal-title":"Blood"},{"key":"R41-20260915","doi-asserted-by":"crossref","first-page":"107595","DOI":"10.1016\/j.leukres.2024.107595","article-title":"Clinical relevance of long non-coding RNA in acute myeloid leukemia: a systematic review with meta-analysis.","volume":"147","author":"Priya","year":"2024","journal-title":"Leuk Res"},{"key":"R42-20260915","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1038\/s41375-024-02381-w","article-title":"A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia.","volume":"38","author":"Koedijk","year":"2024","journal-title":"Leukemia"},{"key":"R43-20260915","doi-asserted-by":"crossref","first-page":"63","DOI":"10.21037\/atm-23-1824","article-title":"Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression.","volume":"12","author":"Urs","year":"2024","journal-title":"Ann Transl Med"},{"key":"R44-20260915","doi-asserted-by":"crossref","first-page":"e25081","DOI":"10.1016\/j.heliyon.2024.e25081","article-title":"Mesenchymal stromal cells in myeloid malignancies: immunotherapeutic opportunities.","volume":"10","author":"Vukotic","year":"2024","journal-title":"Heliyon"},{"key":"R45-20260915","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.3390\/cancers16152615","article-title":"The immune resistance signature of acute myeloid leukemia and current immunotherapy strategies.","volume":"16","author":"Chandra","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R46-20260915","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11899-015-0253-6","article-title":"Role of microenvironment in resistance to therapy in AML.","volume":"10","author":"Tabe","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"key":"R47-20260915","doi-asserted-by":"crossref","first-page":"1207642","DOI":"10.3389\/fcell.2023.1207642","article-title":"Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment.","volume":"11","author":"Fu","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"R48-20260915","doi-asserted-by":"crossref","first-page":"1558496","DOI":"10.3389\/fimmu.2025.1558496","article-title":"Integrated multiomics analysis and machine learning refine neutrophil extracellular trap-related molecular subtypes and prognostic models for acute myeloid leukemia.","volume":"16","author":"Zhong","year":"2025","journal-title":"Front Immunol"},{"key":"R49-20260915","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/bjh.15818","article-title":"Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell\/AML vaccine.","volume":"185","author":"Nahas","year":"2019","journal-title":"Br J Haematol"},{"key":"R50-20260915","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1038\/s41591-024-03271-5","article-title":"Cytokine-mediated CAR T therapy resistance in AML.","volume":"30","author":"Bhagwat","year":"2024","journal-title":"Nat Med"},{"key":"R51-20260915","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1189\/jlb.0605309","article-title":"Functional expression of the CD163 scavenger receptor on acute myeloid leukemia cells of monocytic lineage.","volume":"79","author":"Bachli","year":"2006","journal-title":"J Leukoc Biol"},{"key":"R52-20260915","doi-asserted-by":"crossref","first-page":"e0224543","DOI":"10.1371\/journal.pone.0224543","article-title":"ITGAM is a risk factor to systemic lupus erythematosus and possibly a protection factor to rheumatoid arthritis in patients from Mexico.","volume":"14","author":"Ramirez-Bello","year":"2019","journal-title":"PLoS One"},{"key":"R53-20260915","doi-asserted-by":"crossref","first-page":"e0218323","DOI":"10.1371\/journal.pone.0218323","article-title":"MiR-21 binding site SNP within ITGAM associated with psoriasis susceptibility in women.","volume":"14","author":"Hruska","year":"2019","journal-title":"PLoS One"},{"key":"R54-20260915","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.21037\/tcr-24-810","article-title":"ITGAM sustains MAPK signaling and serves as an adverse prognostic factor and therapeutic target in acute myeloid leukemia.","volume":"13","author":"Zhou","year":"2024","journal-title":"Transl Cancer Res"},{"key":"R55-20260915","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fmed.2018.00052","article-title":"CD11b activity modulates pathogenesis of lupus nephritis.","volume":"5","author":"Khan","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"R56-20260915","doi-asserted-by":"crossref","first-page":"16445","DOI":"10.18632\/aging.203166","article-title":"Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"R57-20260915","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor.","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"R58-20260915","doi-asserted-by":"crossref","first-page":"e57246","DOI":"10.1371\/journal.pone.0057246","article-title":"The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls.","volume":"8","author":"Ding","year":"2013","journal-title":"PLoS One"},{"key":"R59-20260915","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.7314\/APJCP.2013.14.4.2439","article-title":"Associations of IL-10 gene polymorphisms with acute myeloid leukemia in Hunan, China.","volume":"14","author":"Yao","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"R60-20260915","doi-asserted-by":"crossref","first-page":"1409945","DOI":"10.3389\/fimmu.2024.1409945","article-title":"Immune infiltration-related genes regulate the progression of AML by invading the bone marrow microenvironment.","volume":"15","author":"Yu","year":"2024","journal-title":"Front Immunol"},{"key":"R61-20260915","doi-asserted-by":"crossref","first-page":"1359832","DOI":"10.3389\/fphar.2024.1359832","article-title":"Identification of hub genes and potential molecular mechanisms related to drug sensitivity in acute myeloid leukemia based on machine learning.","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Pharmacol"},{"key":"R62-20260915","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ijc.28348","article-title":"CD82 regulates STAT5\/IL-10 and supports survival of acute myelogenous leukemia cells.","volume":"134","author":"Nishioka","year":"2014","journal-title":"Int J Cancer"},{"key":"R63-20260915","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1182\/blood-2002-11-3414","article-title":"Expression of the hemoglobin scavenger receptor (CD163\/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia.","volume":"101","author":"Walter","year":"2003","journal-title":"Blood"},{"key":"R64-20260915","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2141.2002.03790.x","article-title":"Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids.","volume":"119","author":"Schaer","year":"2002","journal-title":"Br J Haematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:00:41Z","timestamp":1789498841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":64,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044062","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2025-01-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}